Health Check: Personalised mRNA Cancer Vaccine Trial Slashes Melanoma Recurrence Risk | Moderna
By India Today
Merck and Moderna have tested an experimental personalised mRNA cancer vaccine, intismeran, on melanoma patients following tumour resection surgery. Administered alongside the immunotherapy drug Keytruda, the combination regimen cut the risk of cancer recurrence or death by 42 percent after two years, with 82 percent…
Read it in your languageMachine translation by Google of the publisher's page
More in Health
From the blog
Box Office
Swati Gupta2 min read
Heart Of The Beast Worldwide Box Office: Inches Away From Beating 2nd Highest-Grossing Insidious Film Soon!
Heart of the Beast starring Brad Pitt is performing well at the box office worldwide despite the competition. It is…
Swati Gupta2 min read
BravoSwati Gupta3 min read
Charmed By A Southern Monster: Release Date Date & All We Know About Bravo’s First Scripted Microdrama Starring Craig Conover
Craig Conover is about to cause more drama, but this time the fictional kind, with his new microdrama series with…
Swati Gupta3 min read
Bollywood FeaturesSwati Gupta2 min read
Shah Rukh Khan’s King Poster Hits Fan Frenzy: How A 1999 Baadshah Line Came Full Circle Ahead Of Christmas 2026!
Shah Rukh Khan's King poster sparks a fan frenzy has they say, 'Aashiq Hu Main, Qaatil Bhi Hoon' To 'Qaatil…
Swati Gupta2 min read